FCGR3A and neoplasm: Moreover, CD16 expression facilitates not only the combination of transferred NK cells with tumor-targeting monoclonal antibodies to exploit ADCC, but it also plays a crucial role in functionality of Bi- or Tri-specific killer engagers containing a single-chain scFv against the tumor antigen and CD16 (72).